BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2567223)

  • 1. The actions of verapamil at the neuromuscular junction.
    Ribera AB; Nastuk WL
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1989; 93(1):137-41. PubMed ID: 2567223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ruthenium red reduces acetylcholine sensitivity and increases desensitization at the frog neuromuscular junction.
    Ribera AB; Nastuk WL
    Neuroscience; 1987 Nov; 23(2):739-44. PubMed ID: 2449634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre- and postsynaptic actions of valproic acid at the frog neuromuscular junction.
    Alkadhi KA; Banks FW
    Brain Res; 1984 Jul; 306(1-2):388-90. PubMed ID: 6087980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre- and postsynaptic effects of the calcium channel blocker verapamil at neuromuscular junctions.
    Sharifullina ER; Afzalov RA; Talantova MV; Vyskochil F; Giniatullin RA
    Neurosci Behav Physiol; 2002; 32(3):309-15. PubMed ID: 12135345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotinic agonists antagonize quantal size increases and evoked release at frog neuromuscular junction.
    Van der Kloot W
    J Physiol; 1993 Aug; 468():567-89. PubMed ID: 8254525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The action of verapamil on the rate of spontaneous release of transmitter at the frog neuromuscular junction.
    Publicover SJ; Duncan CJ
    Eur J Pharmacol; 1979 Feb; 54(1-2):119-27. PubMed ID: 33814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Verapamil alters the amplitude and time course of miniature endplate current.
    Edeson RO; Madsen BW; Milne RK
    Neuropharmacology; 1985 Jun; 24(6):561-5. PubMed ID: 2991805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of the "calcium-antagonist" verapamil on muscle action potentials in the frog and crayfish and on neuromuscular transmission in the crayfish.
    Van Der Kloot W; Kita H
    Comp Biochem Physiol C Comp Pharmacol; 1975 Jan; 50(1):121-5. PubMed ID: 240613
    [No Abstract]   [Full Text] [Related]  

  • 9. The action of polymyxin B at the frog neuromuscular junction.
    Durant NN; Lambert JJ
    Br J Pharmacol; 1981 Jan; 72(1):41-7. PubMed ID: 6112033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of hypertonic saline on quantal size and synaptic vesicles in identified neuromuscular junction of the frog.
    Kriebel ME; Pappas GD
    Neuroscience; 1987 Nov; 23(2):745-56. PubMed ID: 3501849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre- and postjunctional neuromuscular blockade by carbachol.
    Volle RL; Henderson EG
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 291(4):359-70. PubMed ID: 1082104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pre- and postsynaptic effects of the calcium channel blocker verapamil in the nerve-muscle preparation].
    Sharifullina ER; Afzalov RA; Talantova MB; Vyskocil F; Giniatullin RA
    Ross Fiziol Zh Im I M Sechenova; 2000 Oct; 86(10):1314-22. PubMed ID: 11200333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of memantine on the frog neuromuscular junction.
    Masuo K; Enomoto K; Maeno T
    Eur J Pharmacol; 1986 Nov; 130(3):187-95. PubMed ID: 3025001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of emetine and dehydroemetine at the frog neuromuscular junction.
    Alkadhi KA
    Eur J Pharmacol; 1987 Jun; 138(2):257-64. PubMed ID: 2887439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes of quantal transmitter release caused by gadolinium ions at the frog neuromuscular junction.
    Molgó J; del Pozo E; Baños JE; Angaut-Petit D
    Br J Pharmacol; 1991 Sep; 104(1):133-8. PubMed ID: 1686201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of an L-type Ca2+ channel antagonist on activity- and phosphorylation-enhanced release of acetylcholine at the neuromuscular junction of the frog in vitro.
    Arenson MS; Gill DS
    Eur J Neurosci; 1996 Mar; 8(3):437-45. PubMed ID: 8963434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further comparison of the effects of physostigmine and neostigmine on frog neuromuscular transmission.
    Alderdice MT
    Clin Exp Pharmacol Physiol; 1982; 9(1):35-43. PubMed ID: 6284424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of diazepam on the frog neuromuscular junction.
    Vyskocil F
    Eur J Pharmacol; 1978 Mar; 48(1):117-24. PubMed ID: 25188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endplate blocking actions of lophotoxin.
    Atchison WD; Narahashi T; Vogel SM
    Br J Pharmacol; 1984 Jul; 82(3):667-72. PubMed ID: 6146369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre- and postjunctional blocking effects of aminoglycoside, polymyxin, tetracycline and lincosamide antibiotics.
    Singh YN; Marshall IG; Harvey AL
    Br J Anaesth; 1982 Dec; 54(12):1295-306. PubMed ID: 6293521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.